{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:42:05Z","timestamp":1788381725496,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1186\/s13052-018-0551-4","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T13:08:24Z","timestamp":1542200904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses"],"prefix":"10.1186","volume":"44","author":[{"given":"Miriam","family":"Rigoldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"551_CR1","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W, et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3421\u201352."},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/08035250510031584","volume":"94","author":"S Vijay","year":"2005","unstructured":"Vijay S, Wraith JE. Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005;94:872\u20137.","journal-title":"Acta Paediatr"},{"key":"551_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","volume":"29","author":"LA Clarke","year":"2015","unstructured":"Clarke LA, Hollak CEM. The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders. Best Practice Res Clin Endocrinol Metab. 2015;29:219\u201335.","journal-title":"Best Practice Res Clin Endocrinol Metab"},{"issue":"2","key":"551_CR4","first-page":"196","volume":"24","author":"R Cimaz","year":"2006","unstructured":"Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, et al. Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome. Clin Exp Rheumatol. 2006;24(2):196\u2013202.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"551_CR5","first-page":"1","volume":"19","author":"MT Mascia","year":"2015","unstructured":"Mascia MT. Proposta della compilazione di un\u2019anamnesi semistrutturata da parte del paziente come screening nelle popolazioni a rischio di mucopolisaccaridosi (MPS). Medici Oggi (ISSN 1721\u20130208. 2015;19(1):1\u20134.","journal-title":"Medici Oggi"},{"key":"551_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","volume":"10","author":"CJ Hendriksz","year":"2013","unstructured":"Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, et al. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013;10:54\u201364.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"551_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ymgme.2014.12.299","volume":"114","author":"B Yund","year":"2015","unstructured":"Yund B, Rudser K, Ahmed A, Kovac V, Nestrasil I, Raiman J, et al. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II. Mol Genet Metab. 2015;114(2):170\u20137.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"551_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2014.25","volume":"16","author":"M Beck","year":"2014","unstructured":"Beck M, Arn P, Giugliani R, Muenzer J, Okuyama T, Taylor J, et al. The natural history of MPS I: global perspectives from the MPS I registry. Genet Med. 2014;16(10):759\u201365.","journal-title":"Genet Med"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10545-010-9113-7","volume":"33","author":"JA Thomas","year":"2010","unstructured":"Thomas JA, Beck M, Clarke JT, Cox GF. Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I. J Inherit Metab Dis. 2010;33:421\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymgmr.2016.07.006","volume":"8","author":"S Bruni","year":"2016","unstructured":"Bruni S, Lavery C, Broomfield A. The diagnostic journey of patients with mucopolysaccharidosis I: a real-world survey of patient and physician experiences. Mol Genet Metab Rep. 2016;8:67\u201373.","journal-title":"Mol Genet Metab Rep"},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10067-013-2423-z","volume":"33","author":"A Jurecka","year":"2014","unstructured":"Jurecka A, Zakharova E, Malinova V Voskoboeva E, Tylki-Szyma\u0144ska A. Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature. Clin Rheumatol. 2014;33:725\u201331.","journal-title":"Clin Rheumatol"},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/B978-0-444-59565-2.00042-3","volume":"113","author":"JE Wraith","year":"2013","unstructured":"Wraith JE. Mucopolysaccharidoses and Mucolipidosis. Handb Clin Neurol. 2013, Chapter 177;113:1723\u20139.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"551_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12891\/ceog1845.2015","volume":"42","author":"M Castorina","year":"2015","unstructured":"Castorina M, Antuzzi D, Richards SM, Cox GF, Xue Y. Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement therapy. Clin Exp Obstet Gynecol. 2015;42(1):108\u201313.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"16","key":"551_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/heartjnl-2015-309258","volume":"102","author":"E Braunlin","year":"2016","unstructured":"Braunlin E, Wang R. Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs. Heart. 2016;102(16):1257\u201362.","journal-title":"Heart"},{"key":"551_CR15","doi-asserted-by":"publisher","unstructured":"Boffi L, Russo P, Limongelli G. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists. Ital J Pediatr. 2018. https:\/\/doi.org\/10.1186\/s13052-018-0560-3 .","DOI":"10.1186\/s13052-018-0560-3"},{"key":"551_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/S1047951109003576","volume":"19","author":"V Fesslova","year":"2009","unstructured":"Fesslova V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, et al. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Yung. 2009;19:170\u20138.","journal-title":"Cardiol Yung"},{"issue":"s1","key":"551_CR17","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.4081\/cardiogenetics.2013.s1.e2","volume":"3","author":"R Parini","year":"2013","unstructured":"Parini R, Bertola F, Russo P. Molecular basis, diagnosis and clinical management of mucopolysaccharidoses. Cardiogenetics. 2013;3(s1):e2.","journal-title":"Cardiogenetics"},{"key":"551_CR18","doi-asserted-by":"publisher","unstructured":"Moretto A, Bosatra M, Marchesini L, Tesoro S. Anesthesiological risks in mucopolysaccharidoses. Ital J Pediatr. 2018. https:\/\/doi.org\/10.1186\/s13052-018-0554-1 .","DOI":"10.1186\/s13052-018-0554-1"},{"key":"551_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, Kampmann C, Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011;34:1183\u201397.","journal-title":"J Inherit Metab Dis"},{"key":"551_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10545-013-9649-4","volume":"37","author":"C Kampmann C Lampe","year":"2014","unstructured":"Kampmann C Lampe C, Whybra-Tr\u00fcmpler C, Wiethoff CM, Mengel E, Arash L, et al. Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy. J Inherit Metab Dis. 2014;37:269\u201376.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"551_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","volume":"51","author":"JL Ashworth","year":"2006","unstructured":"Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006;51(1):1\u201317.","journal-title":"Surv Ophthalmol"},{"key":"551_CR22","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2147\/OPTH.S78368","volume":"9","author":"K Fenzl CR Teramoto","year":"2015","unstructured":"Fenzl CR Teramoto K, Moshirfar M. Ocular manifestations and management recommendations of lysosomal storage disorders: mucopolysaccharidoses. Clin Ophthalmol. 2015;9:1633\u201344.","journal-title":"Clin Ophthalmol"},{"key":"551_CR23","doi-asserted-by":"publisher","unstructured":"Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr. 2018. https:\/\/doi.org\/10.1186\/s13052-018-0559-9 .","DOI":"10.1186\/s13052-018-0559-9"},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-6-72","volume":"6","author":"M Scarpa","year":"2011","unstructured":"Scarpa M, Alm\u00e1ssy Z, Beck M, Bodamer O, Bruce IA, De Meirleir L, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;6:72.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"551_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","volume":"82","author":"WS Sly","year":"1973","unstructured":"Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. J Pediatr. 1973;82(2):249\u201357.","journal-title":"J Pediatr"},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ymgme.2016.01.009","volume":"117","author":"R Parini","year":"2016","unstructured":"Parini R, Jones SA, Harmatz PR, Giugliani R, Mendelsohn N. The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab. 2016;117:438\u201346.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"551_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, et al. The Morquio a clinical assessment program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio a subjects. Mol Genet Metab. 2013;109(1):54\u201361.","journal-title":"Mol Genet Metab"},{"key":"551_CR28","first-page":"1","volume":"18","author":"A Quartel","year":"2015","unstructured":"Quartel A, Hendriksz CJ, Parini R, Graham S, Lin P, Harmatz P. Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome). JIMD Rep. 2015;18:1\u201311.","journal-title":"JIMD Rep"},{"issue":"11","key":"551_CR29","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","volume":"1812","author":"E Oussoren","year":"2011","unstructured":"Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ. Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options. Biochim Biophys Acta. 2011;1812(11):1542\u201356.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"551_CR30","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.joca.2013.08.001","volume":"21","author":"V Opoka-Winiarska","year":"2013","unstructured":"Opoka-Winiarska V, Jurecka A, Emeryk A, Tylki-Szyma\u0144ska A. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation. Osteoarthrit Cartilage. 2013;21(12):1813\u201323.","journal-title":"Osteoarthrit Cartilage"},{"issue":"2","key":"551_CR31","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1542\/peds.2007-1350","volume":"121","author":"R Martin","year":"2008","unstructured":"Martin R, Beck M, Eng CM, Giugliani R, Harmatz P, Mu\u00f1oz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (hunter syndrome). Pediatrics. 2008;121(2):e377\u201386.","journal-title":"Pediatrics"},{"key":"551_CR32","volume-title":"Mucopolysaccharidosis type IVA","author":"DS Regier","year":"2013","unstructured":"Regier DS, Oetgen M, Tanpaiboon P. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. Mucopolysaccharidosis type IVA. Seattle: University of Washington; 2013. GeneReviews\u00ae. (updated March 2016)."},{"issue":"Suppl 5","key":"551_CR33","doi-asserted-by":"publisher","first-page":"v19","DOI":"10.1093\/rheumatology\/ker397","volume":"50","author":"K Morishita","year":"2011","unstructured":"Morishita K, Petty RE. Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology. 2011;50(Suppl 5):v19\u201325.","journal-title":"Rheumatology"},{"key":"551_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-7-18","volume":"7","author":"R Cimaz","year":"2009","unstructured":"Cimaz R, Coppa GV, Kon\u00e9-Paut I, Link B, Pastores GM, Elorduy MR, et al. Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J. 2009;7:18.","journal-title":"Pediatr Rheumatol Online J"},{"key":"551_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","volume":"335","author":"MR Natowicz","year":"1996","unstructured":"Natowicz MR, Short MP, Wang Y, Dickersin GR, Gebhardt MC, Rosenthal DI, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996;335:1029\u201333.","journal-title":"N Engl J Med"},{"key":"551_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/PRM-2010-0103","volume":"3","author":"K White","year":"2010","unstructured":"White K, Kim T, Neufeld JA. Clinical assessment and treatment of carpal tunnel syndrome in the mucopolysaccharidoses: an interdisciplinary approach. J Pediatr Rehabil Med. 2010;3:57\u201362.","journal-title":"J Pediatr Rehabil Med"},{"issue":"2","key":"551_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","volume":"36","author":"KI Berger","year":"2013","unstructured":"Berger KI, Fagondes SC, Giugliani R, Hardy KA, Lee KS, McArdle C, et al. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. 2013;36(2):201\u201310.","journal-title":"J Inherit Metab Dis"},{"key":"551_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/8904_2016_578","volume":"33","author":"C Kampmann","year":"2017","unstructured":"Kampmann C, Wiethoff CM, Huth RG, Staatz G, Mengel E, Beck M, et al. Management of life-threatening tracheal stenosis and tracheomalacia in patients with mucopolysaccharidoses. JIMD Report. 2017;33:33\u20139.","journal-title":"JIMD Report"},{"key":"551_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","volume":"117","author":"S Tomatsu","year":"2016","unstructured":"Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, et al. Obstructive airway in Morquio a syndrome, the past, the present and the future. Mol Genet Metab. 2016;117:150\u20136.","journal-title":"Mol Genet Metab"},{"key":"551_CR40","volume-title":"Mucopolysaccharidosis type I","author":"LA Clarke","year":"2002","unstructured":"Clarke LA. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. Mucopolysaccharidosis type I. Seattle: University of Washington; 2002. GeneReviews\u00ae (updated February 2016)."},{"issue":"4","key":"551_CR41","first-page":"267","volume":"33","author":"M Mesolella","year":"2013","unstructured":"Mesolella M, Cimmino M, Cantone E, Marino A, Cozzolino M, Della Casa R, et al. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience. Acta Otorhinolaryngol Ital. 2013;33(4):267\u201372.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"551_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-6-43","volume":"6","author":"MJ Valstar","year":"2011","unstructured":"Valstar MJ, Marchal JP, Grootenhuis M Colland V, Wijburg FA. Cognitive development in patients with mucopolysaccharidosis type III (Sanfilippo syndrome). Orphanet J Rare Dis. 2011;6:43.","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"551_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1399-0004.1981.tb01821.x","volume":"20","author":"J. J. P. VAN DE Kamp","year":"2008","unstructured":"van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C) Clin Genet 1981;20(2):152\u2013160.","journal-title":"Clinical Genetics"},{"key":"551_CR44","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1542\/peds.2007-0282","volume":"120","author":"A Meyer","year":"2007","unstructured":"Meyer A, Kossow K, Gal A, Muhlhausen C, Ullrich K, Braulke T, Muschol N. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type a). Pediatrics. 2007;120:e1255\u201361.","journal-title":"Pediatrics"},{"key":"551_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","volume":"93","author":"GJ Ruijter","year":"2008","unstructured":"Ruijter GJ, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, et al. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands. Mol Genet Metab. 2008;93:104\u201311.","journal-title":"Mol Genet Metab"},{"key":"551_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","volume":"170","author":"EG Shapiro","year":"2016","unstructured":"Shapiro EG, Nestrasil I, Delaney KA, Rudser K, Kovac V, Nair N, et al. A prospective natural history study of mucopolysaccharidosis type IIIA. J Pediatr. 2016;170:278\u201387.","journal-title":"J Pediatr"},{"issue":"7\u20138","key":"551_CR47","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.clinbiochem.2012.12.014","volume":"46","author":"GV Coppa","year":"2013","unstructured":"Coppa GV, Galeotti F, Zampini L, Galeazzi T, Padella L, Santoro L, et al. Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of mucopolysaccharidosis type IIIA. Clin Biochem. 2013;46(7\u20138):688\u201390.","journal-title":"Clin Biochem"},{"key":"551_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ajmg.c.30142","volume":"145C","author":"U Moog","year":"2007","unstructured":"Moog U, Van Mierlo I, van Schrojenstein Lantman-De Valk HMJ, Spaapen L, Maaskant MA, Curfs LMG. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am J Med Genet C. 2007;145C:293\u2013301.","journal-title":"Am J Med Genet C"},{"key":"551_CR49","doi-asserted-by":"publisher","unstructured":"Filocamo M, Tomanin R, Bertola F, Morrone A. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know. Ital J Pediatr. 2018. https:\/\/doi.org\/10.1186\/s13052-018-0553-2 .","DOI":"10.1186\/s13052-018-0553-2"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-018-0551-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:23:32Z","timestamp":1662423812000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0551-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0551-4","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"16 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patients or their parents\/guardians gave written informed consent to publications of their pictures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"132"}}